If you get your prescription drug coverage through Medicare Part D, you’ll want to pay closer attention than usual this fall. The Trump administration will officially end a federal Medicare Part D premium subsidy program after 2026, and the cuts will take effect for the 2027 coverage year. The move could lead to higher monthly premiums for millions of seniors.
What’s Actually Ending in 2027
For the past two years, the Centers for Medicare & Medicaid Services has been paying insurance companies billions of dollars through something called the Part D Premium Stabilization Demonstration. You never saw this money, and you never applied for it. It worked quietly in the background, going straight to the insurers who sell your drug plan, in exchange for them keeping your monthly premium lower than it otherwise would’ve been. That arrangement expires at the end of 2026, and the administration announced in late July that it won’t be renewed for the 2027 plan year.
It’s worth being clear about what this is and isn’t, because the headlines can make it sound worse than it is. Your Medicare Part D benefit itself isn’t being cut. Nobody is taking away your prescription drug coverage, changing which drugs are covered by law, or asking you to pay the full retail price of your medications. The $2,000 annual cap on your out-of-pocket drug spending is written into federal law and stays right where it is. What’s ending is a temporary cushion that softened your premium, and premiums are only one piece of what you pay.
The practical effect is that insurance companies will set their 2027 prices without that federal money backing them up. CMS says it reviewed the bids insurers submitted for 2027 and concluded they can price their plans on their own now. Whether you feel that decision in your budget depends heavily on which specific plan you’re enrolled in, which is exactly why the next few months matter so much for you.
How Much Your Premium Could Rise
Here’s where you’ll see two different numbers depending on who’s talking, and you deserve both. An administration official acknowledged the move will likely mean higher premiums for about half of Part D recipients. CMS Administrator Dr. Mehmet Oz has said publicly that most beneficiaries will see an increase of less than $10 a month, and that some people will actually see their premiums go down. KFF, an independent health policy research organization, estimates that some enrollees could see increases of as much as $20 a month.
Those figures aren’t necessarily in conflict, and understanding why helps you plan. A statement about what happens to most people and a statement about the worst case at the high end can both be accurate at the same time. If you’re in a plan that leaned heavily on the subsidy, you’re more likely to land near that $20 figure. If you’re in a leaner plan, you might barely notice. Roughly 25 million people are enrolled in stand-alone Part D plans right now, paying an average of about $36 a month, so a $20 increase would be a meaningful jump on a fixed income and a $5 increase would be an annoyance.
The honest answer is that nobody can tell you your number yet, including the people who made the announcement. CMS won’t publish final 2027 premiums and plan-by-plan details until September, and until those bids are approved and posted, even your own insurance company doesn’t have a figure it can quote you. So be careful if you get a call before then from someone promising an exact price for your plan. That information doesn’t exist yet, no matter how convincing the person on the phone sounds.
Why This Change Is Happening
The administration’s argument is that this program was never really about you. Officials say the subsidy functioned as a payout to large insurance corporations, and they’ve pointed to companies like UnitedHealth Group, Humana, and CVS Health’s Aetna as the biggest players in the Part D market. Dr. Oz has characterized the payments as a bailout that’s no longer needed now that the market has settled, and he’s said the goal is returning Part D to normal competitive conditions.
There’s a backstory that explains why the subsidy existed at all. The Inflation Reduction Act of 2022 capped your out-of-pocket drug spending at $2,000 starting in 2025 and shifted more of the cost of expensive medications onto insurers instead of onto you. That was good news at the pharmacy counter, but it left insurers holding a bigger bill, and they responded by raising premiums. The stabilization program was created to blunt that increase during the transition years of 2025 and 2026. Supporters of the program say it protected seniors during a rocky adjustment period. Critics say it papered over a problem with taxpayer money.
You’ll hear this debated in political terms between now and the midterm elections, especially since subsidies for Affordable Care Act marketplace plans have also expired and health care costs are a live issue for voters. You don’t have to pick a side in that argument. What you do have to do is look at your own plan and your own prescriptions, because that’s the part you actually control.
What To Do This Fall
Mark your calendar for the Medicare Annual Enrollment Period, which runs from October 15 through December 7. Any change you make during that window takes effect on January 1. This is your chance to switch to a different Part D plan, move between Original Medicare and Medicare Advantage, or stay right where you are. If you do nothing, you’ll generally be auto-enrolled in your current plan at its new price, which is fine if the new price is fine and costly if it isn’t.
When your plan’s Annual Notice of Change arrives in the mail, usually in late September, don’t set it aside. That document tells you what’s changing about your specific coverage for the coming year, including your new premium, your deductible, and any changes to the plan’s formulary, which is the list of drugs it covers. Read the formulary section carefully. A plan can keep your premium flat and still move one of your medications to a more expensive tier, and that swap can cost you far more over twelve months than a $20 premium bump would.
The smartest comparison you can make isn’t premium against premium. It’s total annual cost against total annual cost. Write down every prescription you take, including the exact dosage, then use the Plan Finder tool at Medicare.gov to see what each available plan would charge you across the whole year once premiums, deductibles, and copays are added together. The plan with the lowest sticker price often isn’t the cheapest one for someone taking your particular list of drugs.
Help That Can Lower Your Costs
If money is tight, find out whether you qualify for Extra Help, also called the Low-Income Subsidy. This federal program can substantially reduce or eliminate your Part D premium and deductible and cap what you pay for covered prescriptions. Plenty of people who qualify never apply because they assume their income is too high, and the eligibility limits are more generous than most folks expect. You can apply through the Social Security Administration at no cost, and applying doesn’t affect your other benefits.
Beyond that, ask your doctor whether a generic or therapeutic alternative exists for any brand-name drug you’re taking, since a single substitution can reshape your yearly total. Look into your state’s Pharmaceutical Assistance Program if it has one, and check whether the manufacturer of an expensive medication offers a patient assistance program. Free, unbiased counseling is also available through your State Health Insurance Assistance Program, or you can contact a licensed agent at Senior Healthcare Solutions who can answer your questions directly.
Conclusion
The bottom line is that you have time and you have options. The subsidy ending doesn’t touch your $2,000 out-of-pocket cap, doesn’t remove your drug coverage, and doesn’t take effect until 2027. What it does is make this fall’s enrollment period more consequential than most years, because the plan that was your best value in 2026 may not hold that title in 2027. Treating your Annual Notice of Change as required reading rather than junk mail is the single most useful thing you can do.
Give yourself an afternoon in October to sit down with your prescription list and compare your real options side by side, and don’t hesitate to ask for help doing it. A conversation with someone who understands how these plans work can save you hundreds of dollars a year and a good deal of second-guessing. For more information about Medicare, please call 866-633-4427 to speak with a Senior Healthcare Solutions Medicare expert.
